CEIPAL SALES CALL TRANSCRIPT
Project: DataViz Enterprise Analytics Platform
Duration: ~4.5 minutes
Participants: Robert Chang (Ceipal Sales Agent), Dr. Patricia Williams (Potential Client - MedCore Pharmaceuticals)

---

Robert: Good afternoon, Dr. Williams. This is Robert Chang from Ceipal. Thank you so much for making time to speak with me today.

Patricia: Good afternoon, Robert. Please, call me Patricia. I have about 30 minutes, so let's make good use of it. Your email mentioned something about enterprise analytics?

Robert: Perfect, and I'll be respectful of your time. Yes, I wanted to discuss our DataViz Enterprise Analytics Platform. I understand that MedCore is managing clinical trial data across multiple sites and that your teams are struggling with real-time visibility into trial progress. Is that accurate?

Patricia: Unfortunately, yes. We're running 23 active clinical trials across 15 countries right now. Our data lives in different systems - CRFs, lab systems, patient databases. Getting a unified view is incredibly difficult. Our analysts spend more time pulling data together than actually analyzing it.

Robert: That's a common challenge we solve. DataViz is specifically built for complex organizations like pharmaceutical companies that need to aggregate data from multiple sources and turn it into real-time insights. May I ask - what are you currently using for analytics?

Patricia: We have Tableau licenses, but honestly, it's not working well for us. The data refresh is manual, it can't handle the volume we're dealing with, and we need people with specific technical skills just to create dashboards. Our executives want answers in real-time, not tomorrow.

Robert: I completely understand. The challenge with traditional BI tools is they were designed for batch processing, not real-time analytics. DataViz is architected differently from the ground up. We use Apache Kafka for real-time data streaming, which means the moment data is entered in any of your source systems, it's available for analysis. No manual refreshes, no waiting.

Patricia: Real-time across multiple data sources? We're talking about SQL databases, MongoDB for unstructured data, S3 buckets with lab results. Can your platform really pull all that together?

Robert: Absolutely. We support over 50 data connectors out of the box - SQL databases like PostgreSQL and MySQL, NoSQL databases including MongoDB, cloud storage like S3 and Azure Blob, and even direct API integrations with platforms like Salesforce and Veeva if you're using those. And if you have a proprietary system, we can build custom connectors.

Patricia: Okay, but here's the critical question - performance. We're talking about terabytes of data. Can your system handle queries at that scale without timing out?

Robert: Performance is where DataViz really shines. We use ClickHouse for our storage layer - it's specifically designed for OLAP queries on massive datasets. We're talking sub-second query response times even on datasets exceeding 10 terabytes. We have pharmaceutical clients processing genome sequencing data, clinical trial results, adverse event reports - all in real-time.

Patricia: Sub-second on 10 terabytes? That seems ambitious.

Robert: I understand the skepticism - it sounds too good to be true. But that's the power of columnar storage and distributed query processing. We actually guarantee 99% of queries under one second in our SLAs. And the system scales horizontally, so as your data grows, we just add more nodes. No performance degradation.

Patricia: What about visualization? We need flexibility - sometimes standard charts work, but often our scientists need very specific visualizations for their research.

Robert: That's where our custom chart builder comes in. We use D3.js under the hood, which gives you essentially unlimited flexibility. You can use our pre-built visualization library - bar charts, line graphs, heatmaps, scatter plots - or your team can create completely custom visualizations using our drag-and-drop interface. No coding required, though if your team wants to code custom visualizations, they can do that too.

Patricia: And dashboards - can we set up role-based access? Our trial coordinators need different views than our executives, and obviously, we have strict data privacy requirements.

Robert: Absolutely critical, especially in pharma. We have granular role-based access control - you can control who sees what data down to the field level. You can also set up audit logging that tracks every query, every dashboard view, every data export. It's SOC 2 compliant and we can work with your compliance team on HIPAA requirements for clinical data.

Patricia: You mentioned executives - one of our biggest challenges is that our C-suite isn't technical. They want insights, not complex dashboards they need to interpret.

Robert: That's where our natural language query feature is game-changing. Your executives can literally type questions in plain English - "What's the enrollment rate for Trial 23?" or "Show me adverse events by site" - and the system generates the appropriate visualization automatically. It uses AI to understand the intent and pull the right data.

Patricia: That's impressive. But I have to be honest, Robert - we're in Q4 budget planning right now, and enterprise analytics projects are expensive. What kind of investment are we talking about?

Robert: That's fair, and I want to be transparent. DataViz is a significant investment because it's solving a significant problem. For an organization of your size and complexity, we're typically in the $400,000 to $600,000 range for the full platform. That includes implementation, custom connectors, training, and the first year of support.

Patricia: [Pause] That's definitely significant. Help me understand the ROI. How do we justify that to our CFO?

Robert: Great question. Let me give you some real numbers. How many FTE hours per week would you estimate your teams spend just wrangling data - pulling reports, reconciling different sources, creating presentations for executives?

Patricia: Easily 200 hours across the analytics team. Probably more.

Robert: So let's say 250 hours per week conservatively. That's about 13,000 hours per year. If the average cost of those resources is $75 per hour, that's almost $1 million per year spent on data preparation instead of analysis. DataViz automates that. Your teams can focus on insights instead of data plumbing. Most clients see ROI within 8-12 months.

Patricia: That's actually a compelling argument. And you mentioned white-label capabilities in your email?

Robert: Yes, we can white-label the entire platform with MedCore branding. This is particularly valuable if you want to provide dashboards to external stakeholders - trial sites, sponsors, regulatory bodies. They see a MedCore-branded analytics portal, which reinforces your brand and capabilities.

Patricia: Interesting. What about implementation timeline? If we decided to move forward, when could we realistically be operational?

Robert: Implementation typically takes 4-6 months depending on the number of data sources and complexity of your integrations. However, I notice that your project would likely be in Q1 next year based on your budget cycle. That would actually work well - we could start discovery and design in January, have you operational by Q2. And we use an agile approach, so you'd see working dashboards after the first sprint.

Patricia: Alright, Robert, you've given me a lot to think about. I'll need to discuss this with our VP of Data Science and our CFO, but I'm interested.

Robert: Completely understandable. What I'd like to propose is a deeper technical demo where we can show you the platform in action with data similar to clinical trials. Would you be open to bringing your VP of Data Science and maybe someone from IT for that conversation?

Patricia: Yes, that makes sense. Let me coordinate with them and get back to you on timing. Can you send me some case studies, particularly any pharmaceutical clients?

Robert: Absolutely. I'll send you three case studies today - we have two pharmaceutical companies and one medical device manufacturer who are using DataViz for clinical and regulatory reporting. I'll also include our technical architecture documentation and security compliance certifications.

Patricia: Perfect. And Robert, one more thing - you mentioned the project is currently on hold pending budget approval. Does that mean Ceipal isn't prioritizing this?

Robert: Great question. The "on hold" status refers to some other client implementations, but for a company like MedCore with your specific needs and timeline, we absolutely have resources available. In fact, enterprise pharma is one of our strategic focus areas.

Patricia: Good to know. Alright, send me those materials and I'll get back to you next week with some potential times for a deeper dive.

Robert: Perfect. Thank you so much for your time, Patricia. I'm excited about the possibility of working with MedCore, and I think DataViz can really transform how you manage clinical trial insights.

Patricia: Thanks, Robert. Talk soon.

---

END OF TRANSCRIPT

CALL OUTCOME: Positive - Follow-up meeting to be scheduled with technical team
NEXT STEPS: Send case studies (pharma focused), technical architecture docs, security compliance certs; await response for technical demo scheduling
PROJECT DISCUSSED: DataViz Enterprise Analytics Platform
KEY PAIN POINTS ADDRESSED: Real-time data aggregation from multiple sources, performance at scale, role-based access, natural language queries, ROI justification, white-label capabilities, regulatory compliance
